BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21948319)

  • 1. Stability studies needed to define the handling and transport conditions of sensitive pharmaceutical or biotechnological products.
    Ammann C
    AAPS PharmSciTech; 2011 Dec; 12(4):1264-75. PubMed ID: 21948319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control and analytical techniques for biopharmaceuticals.
    Robinson CJ; Jones C
    Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment.
    Parenteral Drug Association
    PDA J Pharm Sci Technol; 2007; 61(2 Suppl TR 39):2-19. PubMed ID: 17953229
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2015; (992):1-210, back cover. PubMed ID: 26118121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2009; (953):1-161. PubMed ID: 19621561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical report # 39: cold chain guidance for medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 2005; 59(3 Suppl TR39):1-12. PubMed ID: 16313059
    [No Abstract]   [Full Text] [Related]  

  • 8. Integration of temperature-controlled requirements into pharmacy practice.
    Ziance R; Chandler C; Bishara RH
    J Am Pharm Assoc (2003); 2009; 49(3):e61-7; quiz e68-9. PubMed ID: 19443313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the near-infrared spectroscopy in the pharmaceutical technology.
    Jamrógiewicz M
    J Pharm Biomed Anal; 2012 Jul; 66():1-10. PubMed ID: 22469433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-processing of biological products: regulatory considerations from the CBER perspective.
    Shacter E
    Dev Biol (Basel); 2003; 113():105-7; discussion 115-6. PubMed ID: 14620859
    [No Abstract]   [Full Text] [Related]  

  • 11. Guest editors' note: special issue on recent developments in statistical approaches for chemistry and manufacturing control (CMC) and quality-by-design(QbD).
    Tsong Y; Yang H
    J Biopharm Stat; 2015; 25(2):233. PubMed ID: 25437635
    [No Abstract]   [Full Text] [Related]  

  • 12. Roadmap for implementation of quality by design (QbD) for biotechnology products.
    Rathore AS
    Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacturing of biodrugs: need for harmonization in regulatory standards.
    Sahoo N; Choudhury K; Manchikanti P
    BioDrugs; 2009; 23(4):217-29. PubMed ID: 19697964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-processing strategies for biologicals API manufacturing processes.
    Opitz U
    Dev Biol (Basel); 2003; 113():101-4; discussion 115-6. PubMed ID: 14620858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality by design, process analytical technology, GMP and regulatory affairs.
    Çelik M
    Pharm Dev Technol; 2018 Jul; 23(6):553. PubMed ID: 29785887
    [No Abstract]   [Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical Report No. 38. Manufacturing chromatography systems postapproval changes (ChromPAC): chemistry, manufacturing, and controls documentation.
    PDA Manufacturing Chromatography Systems PAC Taskforce
    PDA J Pharm Sci Technol; 2006 Mar; 60(1 Suppl TR38):1-29. PubMed ID: 16696189
    [No Abstract]   [Full Text] [Related]  

  • 18. Using tolerance intervals for assessment of pharmaceutical quality.
    Dong X; Tsong Y; Shen M; Zhong J
    J Biopharm Stat; 2015; 25(2):317-27. PubMed ID: 25356617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process analytical technology in the pharmaceutical industry: a toolkit for continuous improvement.
    Scott B; Wilcock A
    PDA J Pharm Sci Technol; 2006; 60(1):17-53. PubMed ID: 17089677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (961):1-428, back cover. PubMed ID: 21699061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.